News 17.07.18

Dutch Heart Foundation, UMC Groningen and Pivot Park Screening Centre collaborate on heart failure High number of SMEs benefit greatly from the European Lead Factory

Scientists from UMC Groningen and Pivot Park Screening Centre have started a study with the objective to prevent one of...

Read more
News 12.06.18

Aduro Biotech Announces Initiation of Phase 1b Clinical Trial in Non-Small Cell Lung Cancer

Aduro Biotech Announces Initiation of Phase 1b Clinical Trial in Non-Small Cell Lung Cancer under Janssen Strategic Partnership for ADU-214 in Combination with Nivolumab

Read more
News 01.06.18

Binding term sheet for allogeneic CAR-NK therapies

MolMed and Glycostem announce the execution of a binding term sheet for the development and manufacturing of allogeneic CAR-NK therapies.

Read more
News 22.03.18

Prexton Therapeutics acquired by Lundbeck

H. Lundbeck A/S (Lundbeck) and Prexton Therapeutics BV (Prexton) announced March 16th the signing of a definitive agreement in which Lundbeck will acquire Prexton.

Read more
News 14.03.18

Ardena acquires ChemConnection adding API expertise

Contract development and manufacturing organisation (CDMO) Ardena has acquired ChemConnection.

Read more
News 25.01.18

InnatOss and MediSapiens Receive EU Grant to Personalize Lyme Diagnostics

Recently the number of companies based at Pivot Park reached the milestone of 50!

Read more
News 11.12.17

ImmunoPrecise to Acquire ModiQuest Research BV

IMMUNOPRECISE ANTIBODIES LTD. announces that it has signed a binding letter of intent with ModiQuest Research BV.

Read more
News 02.11.17

Anglo-Dutch research teams awarded Eurostars funding for a €1.1M project to develop a synthetic matrix for 3D organoid cell culture

Researchers at Maastricht University, Noviocell BV (based at Pivot Park) and Cell Guidance Systems Ltd are collaborating on an EU funded Eurostars project to develop fully-defined matrices for the 3D culture of organoids.

Read more
News 05.09.17

Ceres InnatOss to Launch the Nanotrap® Lyme Antigen Test in the EU

Ceres and Innatoss announced today a partnership that will deliver the Nanotrap® Lyme Antigen Test in the EU.

Read more